Evidence map›Paper›PMID 40883609›Full record

ArticleEMBO molecular medicine2025

Pyrin inflammasome-driven erosive arthritis caused by unprenylated RHO GTPase signaling.

Murali K Akula, Elisabeth Gilis, Pieter Hertens, Lieselotte Vande Walle, Mozes Sze, Julie Coudenys, Yunus Incik, Omar Khan, Martin O Bergo, Dirk Elewaut and 3 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Murali K AkulaVIB Center for Inflammation Research, VIB, Ghent, Belgium. Naga.Akula@irc.vib-ugent.be.ORCID http://orcid.org/0000-0002-6418-8300
Elisabeth GilisVIB Center for Inflammation Research, VIB, Ghent, Belgium.
Pieter HertensVIB Center for Inflammation Research, VIB, Ghent, Belgium.ORCID http://orcid.org/0000-0002-8994-5224
Lieselotte Vande WalleDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Mozes SzeVIB Center for Inflammation Research, VIB, Ghent, Belgium.
Julie CoudenysVIB Center for Inflammation Research, VIB, Ghent, Belgium.
Yunus IncikVIB Center for Inflammation Research, VIB, Ghent, Belgium.
Omar KhanCollege of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.ORCID http://orcid.org/0000-0001-7062-4677
Martin O BergoDepartment of Medicine, Huddinge, Karolinska Institutet, Huddinge, Sweden.ORCID http://orcid.org/0000-0002-6915-7140
Dirk ElewautVIB Center for Inflammation Research, VIB, Ghent, Belgium.ORCID http://orcid.org/0000-0003-3979-4824
Andy WullaertVIB Center for Inflammation Research, VIB, Ghent, Belgium.ORCID http://orcid.org/0000-0001-5012-654X
Mohamed LamkanfiDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0002-4898-7663
Geert van LooVIB Center for Inflammation Research, VIB, Ghent, Belgium. geert.vanloo@irc.vib-ugent.be.ORCID http://orcid.org/0000-0002-8427-4775

Funding

EC | European Research Council (ERC) 101101075Fonds Wetenschappelijk Onderzoek (FWO) 3G044718Fonds Wetenschappelijk Onderzoek (FWO) 3G044818Fonds Wetenschappelijk Onderzoek (FWO) 3G090322Fonds Wetenschappelijk Onderzoek (FWO) 3G0H2522Fonds Wetenschappelijk Onderzoek (FWO) G014221NFonds Wetenschappelijk Onderzoek (FWO) G017121NFonds Wetenschappelijk Onderzoek (FWO) G0A3422NFonds Wetenschappelijk Onderzoek (FWO) G0A7O24NFonds Wetenschappelijk Onderzoek (FWO) GOI5722NUGent | Bijzonder Onderzoeksfonds UGent (BOF) 01G00123UGent | Bijzonder Onderzoeksfonds UGent (BOF) BOF/24J/2021/052UGent | Bijzonder Onderzoeksfonds UGent (BOF) BOF.24Y.2019.0032.01Vetenskapradet 2020-06494Wenner-Gren Stiftelserna (Wenner-Gren Foundations) WGF2021-0085
6 · The paper itself

Abstract

Geranylgeranyl pyrophosphate, a non-sterol intermediate of the mevalonate pathway, serves as the substrate for protein geranylgeranylation, a process catalyzed by geranylgeranyl transferase I (GGTase-I). Myeloid-specific deletion of Pggt1b, the gene coding for GGTase-I, leads to spontaneous and severe erosive arthritis in mice; however, the underlying mechanisms remained unclear. In this study, we demonstrate that arthritis in mice with myeloid-specific Pggt1b deficiency is driven by unprenylated GTP-bound small RHO family GTPases, which in turn trigger Pyrin (Mefv) inflammasome activation, GSDMD-dependent macrophage pyroptosis, and IL-1β secretion. We show that although Pggt1b deficiency leads to hyperactivation of RAC1, impaired prenylation alters its proper membrane localization and interaction with effectors, rendering it effectively inactive in vivo. Consequently, unprenylated RHO family signaling promotes Pyrin inflammasome assembly through recruitment to the RAC1 effector IQGAP1. Together, these findings identify a novel inflammatory axis in which non-prenylated RHO GTPase activity promotes spontaneous Pyrin inflammasome activation, pyroptosis, and IL-1β release in macrophages, contributing to inflammatory arthritis in mice.

Indexed as

ArthritisInflammasomesPyrinrho GTP-Binding ProteinsSignal TransductionAlkyl and Aryl TransferasesAnimalsInterleukin-1betaMacrophagesMiceMice, Inbred C57BLMice, KnockoutPyroptosisrac1 GTP-Binding ProteinAlkyl and Aryl Transferasesgeranylgeranyltransferase type-IInflammasomesInterleukin-1betaMefv protein, mousePyrinrac1 GTP-Binding Proteinrho GTP-Binding ProteinsArthritisPrenylationPyrin InflammasomePyroptosisRHO Family GTPases

Identifiers

PMID40883609
PMCPMC12514176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.